Is Dextromethorphan a Concern for Causing a False Positive During Urine Drug Screening

作者: Michael F. Neerman , Chinemerem L. Uzoegwu

DOI: 10.1309/LMC384VVWIPJFXCZ

关键词: Urine drug screeningPhencyclidineDextrorphanImmunoassaySubstance abuseDextromethorphanFalse positive paradoxMedicinePharmacologyEnzyme multiplied immunoassay technique

摘要: The initial screening for drugs of abuse invariably poses the risk false positives due to cross-reactivity. over-the-counter antitussive medication dextromethorphan (DXM) can cause false-positive results phencyclidine (PCP) upon urine drug (UDS). It is believed that DXM also a positive opiates, presumably structural similarities. This could have serious implications, as reported be increasing. However, many these claims are anecdotal, no fully comprehensive studies exist. Furthermore, what been completed reveal does not despite their similarity in structure. Laboratories established cut-off limits opiates screen, and like all presumptive positives, confirmation with more sensitive methods strongly recommended rule out positives. * DXM : dextromethorphan PCP phencyclidine UDS screening DXO dextrorphan CNS central nervous system NMDA N-methyl-D-aspartate DAU abuse-urine EMIT enzyme multiplied immunoassay technique FPIA fluorescence polarization immunoassay RIA radioimmunoassay KIMS kinetic interaction microparticles solution CEDIA cloned donor SAMHSA Substance Abuse Mental Health Services Administration GC-MS gas chromatography-mass spectrometry LC-MS liquid HPLC high-performance chromatography

参考文章(17)
J Kamei, T Mori, H Igarashi, Y Kasuya, Serotonin release in nucleus of the solitary tract and its modulation by antitussive drugs. Research communications in chemical pathology and pharmacology. ,vol. 76, pp. 371- 374 ,(1992)
H Tukiainen, M Silvasti, S Nykänen, U Hänninen, P Kokkonen, P Karttunen, Pharmacokinetics of dextromethorphan and dextrorphan: a single dose comparison of three preparations in human volunteers. International journal of clinical pharmacology, therapy, and toxicology. ,vol. 25, pp. 493- 497 ,(1987)
Joshua Schier, José Eric Dı́az, Avoid unfavorable consequences: dextromethorpan can bring about a false-positive phencyclidine urine drug screen. Journal of Emergency Medicine. ,vol. 18, pp. 379- ,(2000) , 10.1016/S0736-4679(99)00234-6
J. W. Cranston, Abuse of Dextromethorphan Archives of Family Medicine. ,vol. 8, pp. 99- 100 ,(1999) , 10.1001/ARCHFAMI.8.2.99
Timothy R Wolfe, E.Martin Caravati, Massive dextromethorphan ingestion and abuse. American Journal of Emergency Medicine. ,vol. 13, pp. 174- 176 ,(1995) , 10.1016/0735-6757(95)90088-8
Jerzy L. Bem, Richard Peck, Dextromethorphan. An overview of safety issues. Drug Safety. ,vol. 7, pp. 190- 199 ,(1992) , 10.2165/00002018-199207030-00004
Deborah A. Capon, Felix Bochner, Nicole Kerry, Gerd Mikus, Catherine Danz, Andrew A. Somogyi, The Influence of CYP2D6 Polymorphism and Quinidine on the Disposition and Antitussive Effect of Dextromethorphan in Humans Clinical Pharmacology & Therapeutics. ,vol. 60, pp. 295- 307 ,(1996) , 10.1016/S0009-9236(96)90056-9
Alan B. Storrow, Michael Raynard Magoon, John Norton, The Dextromethorphan Defense: Dextromethorphan and the Opioid Screen Academic Emergency Medicine. ,vol. 2, pp. 791- 794 ,(1995) , 10.1111/J.1553-2712.1995.TB03273.X
R. B. McFee, Dextromethorphan: Another "Ecstasy"? Archives of Family Medicine. ,vol. 9, pp. 123- 123 ,(2000) , 10.1001/ARCHFAMI.9.2.123